A TRANSDERMAL HORMONE DELIVERY SYSTEM

Application 47/MUMNP/2006 published 2006-09-01, filed 2006-01-12
A transdermal contraceptive delivery system (TCDS) for fertility control in women is described comprising a backing layer, an adjoining layer of a solid absorption adhesive polymer matrix in which minimum effective daily doses of an estrogen and a progestin are dispersed and released for transdermal absorption. Presently preferred is use of the synthetic estrogen, ethinyl estradiol, and the synthetic progestin, levonorgestrel. Along with these two steroidal contraceptive agents, a combination of several chemical skin permeation enhancing agents, including capric acid, blended at specific weight ratios, ranging from 2.0:1:1:0.8 to 6:1:1:0.8 are homogeneously dispersed in the adhesive polymer matrix. The invention also provides a method of fertility control utilizing the transdermal contraceptive delivery system. Drawing: 8 Sheets Total Pages: 48 Fig. 1

Applicant

AGILE THERAPEUTICS INC.,
ONE TOWER BRIDGE, SUITE 1350, 100 FRONT STREET, WEST CONSHOHOCKEN PENNSYLVANIA 19428, U.S.A.

Inventor

TEA-YEN CHIEN

International Info

Classification: A61F 13/00, 13/02, A61L 15/16
Publication Number: WO 01/37770
Application Date: 2000-11-22

Priority Information

60/167,535 U.S.A. 1999-11-24